GH replacement in adults: interactions with other pituitary hormone deficiencies and replacement therapies
The DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
Severe GH deficiency (GHD) in adults has been described as a clinical entity. However, some of the features associated with GHD could be due to unphysiological and inadequate replacement of other pituitary hormone deficiencies. This may be true for glucocorticoid replacement that lacks a biomarker making dose titration and monitoring difficult. Moreover, oral estrogen replacement therapy decreases IGF1 levels compared with the transdermal route, which attenuates the responsiveness to GH replacement therapy in women. In addition, in untreated female hypogonadism, oral estrogen may augment the features associated with GHD in adult women. Important interactions between the hormones used for replacing pituitary hormone deficiency occur. Introducing GH replacement may unmask both an incipient adrenal insufficiency and central hypothyroidism. Therefore, awareness and proper monitoring of these hormonal interactions are important in order to reach an optimal replacement therapy. This review will focus on the complex hormonal interactions between GH and other pituitary hormones in GHD and in GH replacement.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As GH suppresses the conversion of cortisone to cortisol, patients receiving GC replacement may require higher doses once GH is initiated, and those with low adrenal reserve may be rendered hypoadrenal by the GH therapy (183,187).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [187]
In the citing paper
“The mechanisms underlying the association between either ACTH or TSH deficiency and lower BMD are not clarified”
From Pituitary Disorders and Osteoporosis (2015) · cites this paper as [53]
In the citing paper
“might be a consequence of either deficiencies of pituitary hormones or excessive hormone replacement [47, 53, 54].”
From Pituitary Disorders and Osteoporosis (2015) · cites this paper as [53]
In the citing paper
“Pituitary hormone deficiencies causing hypogonadism, hypothyroidism, or hypoadrenalism may also contribute to bone loss.”
From Pituitary Disorders and Osteoporosis (2015) · cites this paper as [53]
In the citing paper
“It is important to realize that all the various hypothalamus-pituitarytarget organ hormones affect the regulation of each other to some degree (Filipsson and Johannsson, 2009).”
From The hypothalamus-pituitary-thyroid (HPT)-axis and its role in physiology and pathophysiology of other hypothalamus-pituitary functions (2021) · cites this paper as Filipsson and Johannsson, 2009
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 137 · Cited by 50
Research works printed but not linked: 10
- Carroll, 1998, Journal of Clinical Endocrinology & Metabolism, 83, 382, 10.1210/jc.83.2.382 · DOI · Paper page
- 2008, 12, 226
- Bates, 1996, Journal of Clinical Endocrinology & Metabolism, 81, 1169, 10.1210/jc.81.3.1169 · DOI · Paper page
- Sesmilo, 2001, Journal of Clinical Endocrinology & Metabolism, 86, 5774, 10.1210/jc.86.12.5774 · doi:10.1210/jc.86.12.5774 · Paper page
- 2007, Journal of Clinical Endocrinology & Metabolism, 6, 6
- Andersen, 2002, Journal of Clinical Endocrinology & Metabolism, 87, 1068, 10.1210/jc.87.3.1068 · doi:10.1210/jc.87.3.1068 · Paper page
- 1999, Journal of Clinical Endocrinology & Metabolism, 84, 4472, 10.1210/jc.84.12.4472 · doi:10.1210/jc.84.12.4472 · Paper page
- Ferretti, 1999, Journal of Clinical Endocrinology & Metabolism, 84, 924, 10.1210/jc.84.3.924 · doi:10.1210/jc.84.3.924 · Paper page
- Johannsson, 1996, Journal of Clinical Endocrinology & Metabolism, 81, 1575, 10.1210/jc.81.4.1575 · DOI
- Phillip, 1992, Endocrinology, 130, 2865, 10.1210/en.130.5.2865 · doi:10.1210/en.130.5.2865
Metadata
- Authors
- Filipsson, H., & Johannsson, G.
- Affiliations
- Sahlgrenska University Hospital (SE)
- Corresponding author
- Johannsson, Gudmundur
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-11
- Volume
- 161
- Issue
- suppl_1
- Pages
- S85-S95
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2151257982
- Semantic Scholar
- 6a3e22c24af9e70c76e76eb30ee67f86bab256df
- Cited by
- 50
- References
- 137
- Citations by year
- 2026: 1 · 2024: 3 · 2023: 1 · 2022: 1 · 2021: 4 · 2020: 2 · 2019: 4 · 2018: 4 · 2017: 3 · 2016: 4 · 2015: 1 · 2014: 3 · 2013: 6 · 2012: 2
- FWCI
- 0.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- growth hormone deficiency, pituitary hormone deficiency, glucocorticoid replacement therapy, estrogen replacement therapy, insulin-like growth factor I, adrenal insufficiency, central hypothyroidism, hormone crosstalk, dose titration, women
- MeSH terms
- Administration, Cutaneous, Administration, Oral, Adrenal Insufficiency, Adult, Estrogens, Female, Glucocorticoids, Humans, Hypopituitarism, Hypothyroidism, Male, Middle Aged, Pituitary Hormones, Severity of Illness Index, Sex Factors, Thyroxine, Biomarkers, Estrogen Replacement Therapy, Human Growth Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: GH replacement in adults: interactions with other pituitary hormone deficiencies and replacement therapies. https://app.cochat.ai/papers/10.1530/eje-09-0319
- The paper
- Filipsson, H., & Johannsson, G. (2009). GH replacement in adults: interactions with other pituitary hormone deficiencies and replacement therapies. European Journal of Endocrinology. https://doi.org/10.1530/eje-09-0319
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.